Sec. 11. Development of prescription drug abuse prevention and treatment quality measures across each relevant provider setting
176 words·~1 min read·
/bill/113/hr/672/ih/section-11A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Subpart I of part D of title IX of the Public Health Service Act ( 42 U.S.C. 299b-31 et seq. ) is amended by adding at the end the following: The Secretary, acting through the Director of the Agency for Healthcare Research and Quality and in consultation with the Director of the Centers for Disease Control and Prevention, the Administrator of the Substance Abuse and Mental Health Services Administration, and the Director of the Centers for Medicare & Medicaid Services, shall require the development and application of specific prescription drug abuse prevention and treatment quality measures for each relevant health care provider setting, as identified by the Director.
Not later than April 1, 2016, the Secretary shall disseminate the quality measure requirements developed under subsection
(a)to all affected providers. Quality measures developed under this section may be structure-oriented (such as the required presence of a hospital-based treatment program), process-oriented (such as requiring patients to be informed of the addictive qualities of the medication being prescribed), or outcome-oriented (such as assessing family satisfaction with care). .
Connectionstraces to 1
Traces to 1 document
U.S. Code
Citation graph
cites case law
Sec. 11
Development of prescription drug abuse prevention and treatment quality measures across each relevant provider setting
Cites 1Cited by 0 across 0 sources